News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement
|Articles|October 1, 2007

Postle fig 3

Postle fig 3

Advertisement
External Link - article-477103.pdf

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Advertisement

Related Content

Advertisement
Stock.adobe.com

Sanofi Appoints Belén Garijo as Chief Executive Officer

ByNicholas Jacobus
February 12th 2026
Pharmaceutical Executive

Expanding Focus on Data Analytics, Automation, and Early-Stage Strategic Consulting

ByNicholas Jacobus,Kim Boericke
February 12th 2026
Michael Armstrong

Conversation Data is a Powerful Tool: How Pharma Organizations Can Use it to Improve Patient Experiences

ByMichael Armstrong
February 12th 2026
Stock.adobe.com

Pharmaceutical Executive Daily: FDA Issues Refusal-to-File Letter to Moderna

ByNicholas Jacobus
February 11th 2026
Stock.adobe.com

THX Pharma and Biocodex Enter Licensing Agreemnt to Advance Two Drug Candidates Across Multiple Rare Diseases

ByNicholas Jacobus
February 11th 2026
Advertisement
Advertisement

Trending on PharmExec

1

FDA Sends Refusal-to-File Letter to Moderna for Seasonal Influenza Vaccine, Enters Long-Term Agreement with Government of Mexico

2

Today’s China Crucible: What It Means for Pharma

3

FDA Approves Keytruda-Based Regimen for PD-L1–Positive Platinum-Resistant Ovarian Cancer

4

Sanofi Appoints Belén Garijo as Chief Executive Officer

5

Pharmaceutical Executive Daily: FDA Issues Refusal-to-File Letter to Moderna

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us